Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The molecular pathogenesis of prolactinomas has not been elucidated; no mutational changes were found except for RAS mutations in a single aggressive prolactinoma. In prolactinomas, another obstacle is the lack of surgical specimens suitable for molecular analysis, as prolactinomas are rarely resected due to the availability and effectiveness of drug therapy. Changes in gene expression have been sought and detected in the absence of mutational events.